Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features.
Am J Hematol. 2023 Nov;98(11):E338-E340. doi: 10.1002/ajh.27076. Epub 2023 Sep 4.
Am J Hematol. 2023.
PMID: 37665759
No abstract available.
CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL.
Dai HP, Kong DQ, Shen HJ, Cui W, Wang Q, Li Z, Yin J, Kang LQ, Yu L, Wu DP, Tang XW.
Dai HP, et al.
Biomark Res. 2023 Feb 15;11(1):19. doi: 10.1186/s40364-023-00451-2.
Biomark Res. 2023.
PMID: 36793095
Free PMC article.
Item in Clipboard
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia.
Cao X, Dai H, Cui Q, Li Z, Shen W, Pan J, Shen H, Ma Q, Li M, Chen S, Chen J, Zhu X, Meng H, Yang L, Wu D, Tang X.
Cao X, et al.
Exp Hematol Oncol. 2022 Sep 29;11(1):67. doi: 10.1186/s40164-022-00318-6.
Exp Hematol Oncol. 2022.
PMID: 36175988
Free PMC article.
Item in Clipboard
Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.
Tang X, Valdez BC, Ma Y, Zhang Q, Qu C, Dai H, Yin J, Li Z, Xu T, Xu Y, Chen J, Zhu X, Chen Z, Wu D, Andersson BS.
Tang X, et al.
Bone Marrow Transplant. 2021 Jul;56(7):1674-1682. doi: 10.1038/s41409-021-01238-5. Epub 2021 Feb 26.
Bone Marrow Transplant. 2021.
PMID: 33637882
Item in Clipboard
CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease.
Kong D, Qu C, Dai H, Li Z, Yin J, Chen S, Kang L, Chen G, Zhu M, Yu L, Wu D, Tang X.
Kong D, et al.
Br J Haematol. 2020 Oct;191(2):e47-e49. doi: 10.1111/bjh.16982. Epub 2020 Jul 22.
Br J Haematol. 2020.
PMID: 32700338
Free article.
Clinical Trial.
No abstract available.
Item in Clipboard
Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation.
Yang X, Dai H, Kang L, Qu C, Li Z, Yin J, Qiu H, Fu C, Han Y, Jin Z, Ma X, Zhu X, Yu L, Wu D, Tang X.
Yang X, et al.
Hematol Oncol. 2019 Dec;37(5):655-658. doi: 10.1002/hon.2682. Epub 2019 Oct 27.
Hematol Oncol. 2019.
PMID: 31656047
No abstract available.
Item in Clipboard
Cite
Cite